Alterations in calmodulin mRNA expression and calmodulin content in rat brain after repeated, intermittent amphetamine

Molecular Brain Research

Volumn 62, Issue 1, 1998, Pages 35-42

  Michelhaugh, Sharon K ^a   Pimputkar, Gouri ^a   Gnegy, Margaret E ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Behavioral sensitization; Dopamine; Mesencephalon; Nucleus accumbens; RNase protection assay; Striatum

Indexed keywords

AMPHETAMINE; CALMODULIN; MESSENGER RNA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR MODIFICATION; CORPUS STRIATUM; DRUG EFFECT; FEMALE; FOREBRAIN; LIMBIC CORTEX; MESENCEPHALON; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TISSUE DISTRIBUTION;

ALTERNATIVE SPLICING; AMPHETAMINE; ANIMALS; BLOTTING, NORTHERN; BRAIN; BRAIN CHEMISTRY; CALMODULIN; CORPUS STRIATUM; DRUG ADMINISTRATION SCHEDULE; FEMALE; INJECTIONS, INTRAPERITONEAL; MESENCEPHALON; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TIME FACTORS;

ANIMALIA;

EID: 0032512116     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00233-2     Document Type: Article

References (40)

1. Badiani A., Browman K.E., Robinson T.E. Influence of novel versus home environments on sensitization to the psychomotor stimulant effects of cocaine and amphetamine. Brain Res. 674:1995;291-298.
2. Bai G., Weiss B. The increase of calmodulin in PC12 cells induced by NGF is caused by differential expression of multiple mRNAs for calmodulin. J. Cell Physiol. 149:1991;414-421.
3. Berchtold M.W., Egli R., Rhyner J.A., Hameister H., Strehler E.E. Localization of the human bona fide calmodulin genes CALM1, CALM2, and CALM3 to chromosomes 14q24-q31, 2p21.1-p21.3, and 19q13.2-q13.3. Genomics. 16:1993;461-465.
4. Berry F.B., Brown I.R. CaM I mRNA is localized to apical dendrites during postnatal development of neurons in the rat brain. J. Neurosci. Res. 43:1996;565-575.
5. Brady S.T., Tytell M., Heriot K., Lasek R.J. Axonal transport of calmodulin: a physiologic approach to identification of long-term associations between proteins. J. Cell Biol. 89:1981;607-614.
6. Cena V., Garcia A.G., Gonzalez-Garcia C., Kirpekar S.M. Orthograde and retrograde axonal transport of calmodulin in a cat noradrenergic neurone. Br. J. Pharm. 82:1984;143-149.
7. Colomer J., Agell N., Engel P., Alberola-Ila J., Bachs O. Calmodulin expression during proliferative activation of human T lymphocytes. Cell Calcium. 14:1993;609-618.
8. Fallon J.H. Topographic organization of ascending dopaminergic projections. Ann. NY Acad. Sci. 537:1988;1-9.
9. Gannon M.N., McEwen B.S. Distribution and regulation of calmodulin mRNAs in rat brain. Mol. Brain Res. 22:1994;186-192.
10. Gnegy M.E., Hewlett G.H., Pimputkar G. Haloperidol and MK-801 block increases in striatal calmodulin resulting from repeated amphetamine treatment. Brain Res. 734:1996;35-42.
11. Gnegy M.E., Hewlett G.H., Yee S.L., Welsh M.J. Alterations in calmodulin content and localization in areas of rat brain after repeated intermittent amphetamine. Brain Res. 562:1991;6-12.
12. Heffner T.G., Hartman J.A., Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13:1980;453-456.
13. Iwata S., Hewlett G.H., Ferrell S.T., Czernik A.J., Meiri K.F., Gnegy M.E. Increased in vivo phosphorylation state of neuromodulin and synapsin I in striatum from rats treated with repeated amphetamine. J. Pharmacol. Exp. Ther. 278:1996;1428-1434.
14. Karler R., Bedingfield J.B., Thai D.K., Calder L.D. The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine. Brain Res. 757:1997;228-235.
15. Koob G.F., Nestler E.J. The neurobiology of drug addiction. J. Neuropsychiat. Clin. Neurol. 9:1997;482-497. Review, 169 Refs.
16. MacManus J.P., Gillen M.F., Korczak B., Nojima H. Differential calmodulin gene expression in fetal, adult, and neoplastic tissues of rodents. Biochem. Biophys. Res. Commun. 159:1989;278-282.
17. Matsuo K., Ikeshima H., Shimoda K.et al. Expression of the rat calmodulin gene II in the central nervous system: a 294-base promoter and 68-base leader segment mediates neuron-specific gene expression in transgenic mice. Mol. Brain Res. 20:1993;9-20.
18. Michelhaugh S.K., Gnegy M.E. Intermittant amphetamine (amph) alters calmodulin gene expression in the rat brain. Soc. Neurosci. Abstr. 23:1997;520-523.
19. Nichols R.A., Sihra T.S., Czernik A.J., Nairn A.C., Greengard P. Calcium/calmodulin-dependent protein kinase II increases glutamate and noradrenaline release from synaptosomes. Nature. 343:1990;647-651.
20. Nojima H., Kishi K., Sokabe H. Multiple calmodulin mRNA species are derived from two distinct genes. Mol. Cell. Biol. 7:1987;1873-1880.
21. Nojima H., Sokabe H. Structural organization of calmodulin genes in the rat genome. Adv. Exp. Med. Biol. 255:1989;223-232.
22. Ostrander M.M., Hartman J., Bandiani A., Robinson T.E., Gnegy M.E. The effect of environment on the changes in calmodulin in rat brain produced by repeated amphetamine treatment. Brain Res. 797:1998;339-341.
23. Paulson P.E., Camp D.M., Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology. 103:1991;480-492.
24. Pierce R.C., Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25:1997;192-216. Review, 129 Refs.
25. Popov N., Matthies H. Influence of dopamine receptor agonists and antagonists on calmodulin translocation in different brain regions. Eur. J. Pharm. 172:1989;205-210.
26. Roberts-Lewis J.M., Welsh M.J., Gnegy M.E. Chronic amphetamine treatment increases striatal calmodulin in rats. Brain Res. 384:1986;383-386.
27. Robinson T.E. Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats. Psychopharmacology. 84:1984;466-475.
28. T.E. Robinson, The neurobiology of amphetamine psychosis: evidence from studies with an animal model, in: T. Nakazawa (Ed.), Taniguchi Symposia on Brain Sciences, Biological Basis of Schizophrenic Disorders, Tokyo, Japan Scientific Societies Press, 1991, pp. 185-201.
29. Robinson T.E., Becker J.B. Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur. J. Pharm. 85:1982;253-254.
30. Robinson T.E., Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17:1997;8491-8497.
31. Roseboom P.H., Hewlett G.H., Gnegy M.E. Repeated amphetamine administration alters the interaction between D1-stimulated adenylyl cyclase activity and calmodulin in rat striatum. J. Pharmacol. Exp. Ther. 255:1990;197-203.
32. 2. Journal of Biological Chemistry. 238:1963;371-376.
33. Sato M. A lasting vulnerability to psychosis in patients with previous methamphetamine psychosis. Ann. NY Acad. Sci. 654:1992;160-170.
34. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Ann. Rev. Pharm. Tox. 33:1993;639-677. Review, 284 Refs.
35. Shimizu Y., Akiyama K., Kodama M., Ishihara T., Hamamura T., Kuroda S. Alterations of calmodulin and its mRNA in rat brain after acute and chronic administration of methamphetamine. Brain Res. 765:1997;247-258.
36. Sola C., Tusell J.M., Serratosa J. Differential response of calmodulin genes in the mouse brain after systemic kainate administration. Neuroscience. 78:1997;155-164.
37. Sweet S.C., Gnegy M.E., Welsh M.J. Presence of matrix-specific antibodies in affinity-purified polyclonal antibodies. J. Immunol. Methods. 136:1991;31-36.
38. Vezina P., Stewart J. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499:1989;108-120.
39. Vezina P., Stewart J. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res. 516:1990;99-106.
40. Wolf M.E., Dahlin S.L., Hu X.T., Xue C.J., White K. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience. 69:1995;417-439.